Opendata, web and dolomites

H2020 projects about "tumours"

The page lists 173 projects related to the topic "tumours".

# achronym  title  year 
1 B-CAST Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes 2015
2 CRCStemCellDynamics Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers 2015
3 Crosstag Unravelling cross-presentation pathways using a chemical biology approach 2015
4 ONCORNET ONCOgenic Receptor Network of Excellence and Training 2015
5 InSPECT Integrated Spectrometers for Spectral Tissue Sensing 2015
6 VIBRA Very fast Imaging by Broadband coherent RAman 2015
7 Brain Metastases The Role of Circulating Monocytes in the Development of Brain Metastases 2015
8 Tolltum Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment 2015
9 SmartMammaCAD Intelligent Automated System for detecting Diagnostically Challenging Breast Cancers 2015
10 STROMAMECH Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery 2015
11 DC cancer Development and immunological control of dendritic cell cancer 2015
12 breast cancer dormancy Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy 2015
13 ChemoBOOM Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy 2016
14 MACROIMAGING Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages 2015
15 CICCI Characterization of Intestinal Cancer Cell Invasion 2015
16 EGFR-Activ Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights 2015
17 APOBEC Enzymatic DNA deamination and the immunity/cancer balance 2015
18 XMED Medical Phase Contrast X-ray Imaging with Laser Plasma Accelerator 2015
19 NANOTAM Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages 2015
20 RAIL Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy 2015
21 ER_disease Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer 2015
22 LAUREN bLadder cAncer URine cEll aNalysis 2015
23 SPICE Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis 2015
24 ISPIC Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome 2016
25 RNAEDIT RNA EDITING IN HEALTH AND DISEASE 2016
26 MMUVR Elucidating the role of ultraviolet radiation in melanoma 2016
27 COMbAT Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies 2015
28 ONCOCHECK A simple blood test to monitor disease progression in patients undergoing cancer therapy 2015
29 MaXIMA Three dimensional breast cancer models for X-ray Imaging research 2016
30 ClearPEMplus Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography. 2015
31 GLINT GlucoCEST Imaging of Neoplastic Tumours 2016
32 CARAT Chimeric Antigen Receptors (CARs) for Advanced Therapies 2016
33 FORCE Imaging the Force of Cancer 2016
34 CONQUEST Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies 2016
35 PrECISE PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION 2016
36 NoCut Detection of Chromatin Bridges during Cytokinesis 2016
37 LDC4PCaTher BMX-targeted ligand-drug conjugates for prostate cancer therapy 2016
38 iGEMMdev Development and Characterisation of New Immunogenic GEMMs of Lung Cancer 2017
39 PrecTherLSCC Precision Therapies in Lung Squamous Cell Carcinoma 2016
40 NuSiCC Modelling the therapeutic potential of NUAK1 suppression in colorectal cancer 2016
41 INTO Inorganic therapeutic nanoparticles for osteoporosis 2016
42 AVITAG Alphaviral Immunotherapy against Glioblastoma 2016
43 CIRCLE Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia 2016
44 LDMBI Low dose Molecular Breast Imaging for improved cancer detection in dense breast tissue. 2016
45 TSGPs-of-CFSs Role of Tumour Suppressor Gene Products of Common Fragile Sites in Human Diseases 2016
46 NanoPokers Deciphering cell heterogeneity in tumors using arrays of nanowires to controllably poke single cells in longitudinal studies 2016
47 ONCOINTRABODY Targeting common oncogenes with intracellular monobodies 2016
48 DECODE Allele-specific Deconvolution of Tumour DNA Methylation and Expression Data toReveal Underlying Cell Populations 2016
49 CLONCELLBREAST CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT 2017
50 LeukaemiaTargeted Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine 2016
51 GlioDx GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients 2016
52 INTHER Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy 2016
53 Quality2Cells TimeLapseReader for Quality Control of Immune Cells used for Cell-Based Therapies 2016
54 MATRICAN Matrix during cancer progression 2016
55 BITCAT Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy 2017
56 CONQUEST CONQUEST: Enabling advanced medical imaging 2016
57 N2B-patch Nose to Brain Delivery of antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device 2017
58 McHAP Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP 2017
59 NONCODRIVERS Finding noncoding cancer drivers 2016
60 EURE-CART EURopean Endeavour for Chimeric Antigen Receptor Therapies 2017
61 MONONANOCHEM In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer 2017
62 SpheroPredict A 3D advanced test for prediction of drug response in secondary liver cancer 2017
63 Curtana Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers 2017
64 BGCI Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology 2017
65 BRECASTEM Functional and Molecular Characterisation of Breast Cancer Stem Cells 2017
66 GlycoModels 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management 2017
67 Survive Surviving metabolism: acid handling and signalling 2017
68 MicroMechCell Precision micromechanical lever for next-generation cell culture systems 2017
69 SCALTIE Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy 2017
70 OPN-Can Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models 2017
71 GlimS Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. 2017
72 IVORIaN RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. 2017
73 PI3K-VAs Activation of PI3K signalling in the pathogenesis of Vascular Anomalies 2018
74 DSMT16 Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer 2018
75 PHRD The development of Personalised Host Response Diagnostic kit 2017
76 BEAT The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential. 2017
77 META-DORM Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions 2018
78 altEJrepair Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy 2017
79 DissectPcG Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity 2017
80 X-Imaging MRI diagnosis using a single-shot imaging technique with unprecedented robustness to field inhomogeneities 2017
81 OR-HMC Assay for cancer diagnostics by quantification of 5hmC 2017
82 Tumor-Treg-Targeting Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours 2018
83 u-PBeam Microdosimetry study of a new radiation therapy method based on proton minibeams 2017
84 AiPBAND An Integrated Platform for Developing Brain Cancer Diagnostic Techniques 2018
85 CuHypMECH New Nuclear Medicine Imaging Radiotracer 64Cu(II) for diagnosing Hypoxia Conditions Based on the Cellular Copper Cycle 2017
86 GLIOTRAIN Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics 2017
87 onCOMBINE Towards evidence-based combinations of approved and novel cancer drugs 2017
88 TarMyc Targeting the Oncogenic Function of Myc in vivo 2018
89 HypoRuLight Hypoxic Tumour Models for Photoactivatable Ruthenium-based Chemotherapy 2017
90 EDIReX EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts 2018
91 CylcoRu4PACT Cyclometallated ruthenium complexes for photo-activated chemotherapy 2018
92 ToMeTuM Towards the Understanding a Metal-Tumour-Metabolism 2018
93 CANCER Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life 2018
94 SDS-OmiProbe Revolutionary opto-biological methodology for aggressive HER2 cancer 2017
95 DiSect The Tumour Stroma as a Driver of Clonal Selection 2018
96 HepaCheC HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer 2018
97 NIRCOThera Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy 2018
98 CellularNanoMachines Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer 2019
99 DYNAFLUORS Dynamic Activatable Fluorophores 2018
100 PhenoSwitch Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate. 2018
101 MicroC Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance 2018
102 VALSL Valorisation of splice-switching oligonucleotides for lung cancer therapy 2018
103 SPeNTa-Brain Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours 2019
104 NanoFEITH Nanoparticles for Fluorescence-Enhanced Imaging and Therapy of Breast Cancer 2018
105 ORTHOCAT Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs 2018
106 MITIG Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism 2019
107 Gal3-BrainMets A novel immunotherapy against brain metastasis: Anti-Galectin-3 2019
108 HDAC6_GEMM Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. 2018
109 NANOBOTS Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers 2018
110 4DBIOSERS Four-Dimensional Monitoring of Tumour Growth by Surface Enhanced Raman Scattering 2018
111 EVO-NANO Evolvable platform for programmable nanoparticle-based cancer therapies 2018
112 HOPE Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 2018
113 DISCOVER Death receptor signalling in tumour immune editing 2018
114 KERMA A NEW VERIFICATION SYSTEM FOR COMPLEX RADIOTHERAPY TREATMENTS 2018
115 SenolT Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence 2018
116 TARGETSS Targeting SWI/SNF complex function in cancer 2019
117 ARTTOUCH Generating artificial touch: from the contribution of single tactile afferents to the encoding of complex percepts, and their implications for clinical innovation 2019
118 CL-IO Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis 2018
119 CytoPro A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up 2018
120 PRIMAGE PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers 2018
121 GLADIATOR Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces 2019
122 FRINGE Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies 2019
123 CANCEREVO Deciphering and predicting the evolution of cancer cell populations 2019
124 FanCY Flow and Deformation of Cancer tumours near Yielding 2019
125 PROTONMBRT Spatial fractionation of the dose in proton therapy: a novel therapeutic approach 2019
126 ONCOFUM Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition 2019
127 iPC individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology 2019
128 PRO-TOOLKITS Programmable nucleic acid toolkits for cell-free diagnostics and genetically encoded biosensing 2019
129 PICModForPCa Personalised Image-based Computational Modelling Framework to Forecast Prostate Cancer 2020
130 SYNKIT Synthetic Natural Killer Cells for Immunotherapy 2020
131 Oncogenic PI3-kinase New biology of oncogenic PI 3-kinase 2019
132 GLIOHAB Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation 2019
133 THERMOGUIDE Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance 2019
134 EVOMET The rise and fall of metastatic clones under immune attack 2019
135 DC Metabolism Metabolic Regulation of Conventional Dendritic Cell Development and Function 2020
136 MacrophInt Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance 2019
137 MHT-ImmunoEnhancer Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment 2019
138 PRINT-CHEMO To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. 2019
139 CentrosoTME The role of extra centrosomes on the tumour microenvironment 2019
140 PanILC Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia 2019
141 PhotoStem Photoswitching molecules for the spatiotemporal control of cancer stem cells with light 2019
142 INFORM Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs 2020
143 CancerADAPT Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits 2019
144 MICROX Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform 2019
145 TargetGBM Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma 2019
146 TARGLIO Improved glioblastoma treatment through targeted, local drug delivery 2019
147 INTRA The first ultrasound-compatible cranial prosthesis enabling diagnostic and therapeutic use of ultrasound in brain pathologies 2019
148 PROTEUS Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection 2019
149 SIMCARE SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment 2019
150 MS Unravelling the molecular and cellular mechanism of metastasis 2020
151 RASImmune Targeting RAS driven tumour immune evasion 2019
152 MABIOS The first microalgae platform for the production of anticancer biopharmaceuticals 2019
153 TK-NEO Personalized Cancer Immunotherapy through DNA-EP vaccines 2019
154 VISIOCYT VISIOCYT SCREENING: A DISRUPTIVE ARTIFICIAL INTELLIGENCE SOLUTION FOR BLADDER CANCER SCREENING 2019
155 RASMAC Regulatory Approved Software for Mutation Analysis in Cancer 2019
156 ONCORNET2.0 ONCOgenic Receptor Network of Excellence and Training 2.0 2020
157 MYCure Innovative cancer therapy through Myc inhibition: taking OMO-103 to market 2019
158 CellSex The importance of cellular sex in physiology and the underlying mechanisms 2020
159 HIL PT System A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment 2019
160 CSI AurkA-MYC Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds 2019
161 BioTrace World's First Real-Time Monitoring System for Ablation Procedures 2019
162 EARLYDETECT Development of an accurate, early diagnostic tool for ovarian cancer 2020
163 CHROMREP Dissecting the chromatin response to DNA damage in silenced heterochromatin regions 2019
164 STI-001 Turn Cancer Immunotherapy Effective in Most Patients 2019
165 AMPLITUDE Advanced Multimodal Photonics Laser Imaging Tool for Urothelial Diagnosis in Endoscopy 2020
166 oncNGS NGS diagnostics in 21st century oncology: the best, for all, at all times 2020
167 PROSTATOR Reliable urinary test for the diagnosis of prostate cancer 2020
168 KineTic New Reagents for Quantifying the Routing and Kinetics of T-cell Activation 2020
169 BRCAstem Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells 2020
170 NANOCRISPR NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS 2021
171 PDASwITch Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer 2020
172 RCC_Evo Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer 2020
173 HypoCyclo Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions 2020